The Queensland Parkinson’s Project: An Overview of 20 Years of Mortality from Parkinson’s Disease

Objective The consensus is that life expectancy for individuals with Parkinson’s disease (PD) is reduced, but estimations vary. We aimed to provide an overview of 20 years of mortality and risk factor data from the Queensland Parkinson’s Project. Methods The analysis included 1,334 PD and 1,127 cont...

Full description

Bibliographic Details
Main Authors: Peter Cornelis Poortvliet, Alexander Gluch, Peter A. Silburn, George D. Mellick
Format: Article
Language:English
Published: Korean Movement Disorders Society 2021-01-01
Series:Journal of Movement Disorders
Subjects:
Online Access:http://www.e-jmd.org/upload/jmd-20034.pdf
id doaj-381b3097ebe74838b82760cd383de8aa
record_format Article
spelling doaj-381b3097ebe74838b82760cd383de8aa2021-01-27T06:08:08ZengKorean Movement Disorders SocietyJournal of Movement Disorders2005-940X2093-49392021-01-01141344110.14802/jmd.20034318The Queensland Parkinson’s Project: An Overview of 20 Years of Mortality from Parkinson’s DiseasePeter Cornelis Poortvliet0Alexander Gluch1Peter A. Silburn2George D. Mellick3 Griffith Institute for Drug Discovery, School of Environment and Science, Griffith University, Brisbane, Australia Griffith Institute for Drug Discovery, School of Environment and Science, Griffith University, Brisbane, Australia Queensland Brain Institute, University of Queensland, Brisbane, Australia Griffith Institute for Drug Discovery, School of Environment and Science, Griffith University, Brisbane, AustraliaObjective The consensus is that life expectancy for individuals with Parkinson’s disease (PD) is reduced, but estimations vary. We aimed to provide an overview of 20 years of mortality and risk factor data from the Queensland Parkinson’s Project. Methods The analysis included 1,334 PD and 1,127 control participants. Preliminary analysis of baseline characteristics (sex, age at onset, family history, smoking status, pesticide exposure, depression and neurosurgery) was conducted, and Kaplan–Meier curves were generated for each potential risk factor. Standardized mortality ratios (SMRs) were calculated comparing this cohort to the general Australian population. Cox proportional hazards regression modeling was used to analyze potential predictors of mortality. Results In total, 625 (46.8%) PD and 237 (21.0%) control participants were deceased. Mean disease duration until death was 15.3 ± 7.84 years. Average ages at death were 78.0 ± 7.4 years and 80.4 ± 8.4 years for the deceased PD and control participants, respectively. Mortality was significantly increased for PD in general {SMR = 2.75 [95% confidence interval (CI): 2.53–2.96]; p = 0.001}. SMRs were slightly higher for women and those with an age of onset before 60 years. Multivariate analysis showed that deep brain stimulation (DBS) treatment was associated with lower mortality [hazard ratio (HR) = 0.76; 95% CI: 0.59–0.98], while occasional pesticide exposure increased mortality risk (HR = 1.48; 95% CI: 1.17–1.88). Family history of PD, smoking and depression were not independent predictors of mortality. Conclusion Mortality in PD is increased. Sex, age at onset and occasional pesticide exposure were independent determinants of increased mortality, while DBS treatment was associated with reduced mortality.http://www.e-jmd.org/upload/jmd-20034.pdfdeep brain stimulationlife expectancymortalityparkinson’s diseaseprognostication
collection DOAJ
language English
format Article
sources DOAJ
author Peter Cornelis Poortvliet
Alexander Gluch
Peter A. Silburn
George D. Mellick
spellingShingle Peter Cornelis Poortvliet
Alexander Gluch
Peter A. Silburn
George D. Mellick
The Queensland Parkinson’s Project: An Overview of 20 Years of Mortality from Parkinson’s Disease
Journal of Movement Disorders
deep brain stimulation
life expectancy
mortality
parkinson’s disease
prognostication
author_facet Peter Cornelis Poortvliet
Alexander Gluch
Peter A. Silburn
George D. Mellick
author_sort Peter Cornelis Poortvliet
title The Queensland Parkinson’s Project: An Overview of 20 Years of Mortality from Parkinson’s Disease
title_short The Queensland Parkinson’s Project: An Overview of 20 Years of Mortality from Parkinson’s Disease
title_full The Queensland Parkinson’s Project: An Overview of 20 Years of Mortality from Parkinson’s Disease
title_fullStr The Queensland Parkinson’s Project: An Overview of 20 Years of Mortality from Parkinson’s Disease
title_full_unstemmed The Queensland Parkinson’s Project: An Overview of 20 Years of Mortality from Parkinson’s Disease
title_sort queensland parkinson’s project: an overview of 20 years of mortality from parkinson’s disease
publisher Korean Movement Disorders Society
series Journal of Movement Disorders
issn 2005-940X
2093-4939
publishDate 2021-01-01
description Objective The consensus is that life expectancy for individuals with Parkinson’s disease (PD) is reduced, but estimations vary. We aimed to provide an overview of 20 years of mortality and risk factor data from the Queensland Parkinson’s Project. Methods The analysis included 1,334 PD and 1,127 control participants. Preliminary analysis of baseline characteristics (sex, age at onset, family history, smoking status, pesticide exposure, depression and neurosurgery) was conducted, and Kaplan–Meier curves were generated for each potential risk factor. Standardized mortality ratios (SMRs) were calculated comparing this cohort to the general Australian population. Cox proportional hazards regression modeling was used to analyze potential predictors of mortality. Results In total, 625 (46.8%) PD and 237 (21.0%) control participants were deceased. Mean disease duration until death was 15.3 ± 7.84 years. Average ages at death were 78.0 ± 7.4 years and 80.4 ± 8.4 years for the deceased PD and control participants, respectively. Mortality was significantly increased for PD in general {SMR = 2.75 [95% confidence interval (CI): 2.53–2.96]; p = 0.001}. SMRs were slightly higher for women and those with an age of onset before 60 years. Multivariate analysis showed that deep brain stimulation (DBS) treatment was associated with lower mortality [hazard ratio (HR) = 0.76; 95% CI: 0.59–0.98], while occasional pesticide exposure increased mortality risk (HR = 1.48; 95% CI: 1.17–1.88). Family history of PD, smoking and depression were not independent predictors of mortality. Conclusion Mortality in PD is increased. Sex, age at onset and occasional pesticide exposure were independent determinants of increased mortality, while DBS treatment was associated with reduced mortality.
topic deep brain stimulation
life expectancy
mortality
parkinson’s disease
prognostication
url http://www.e-jmd.org/upload/jmd-20034.pdf
work_keys_str_mv AT petercornelispoortvliet thequeenslandparkinsonsprojectanoverviewof20yearsofmortalityfromparkinsonsdisease
AT alexandergluch thequeenslandparkinsonsprojectanoverviewof20yearsofmortalityfromparkinsonsdisease
AT peterasilburn thequeenslandparkinsonsprojectanoverviewof20yearsofmortalityfromparkinsonsdisease
AT georgedmellick thequeenslandparkinsonsprojectanoverviewof20yearsofmortalityfromparkinsonsdisease
AT petercornelispoortvliet queenslandparkinsonsprojectanoverviewof20yearsofmortalityfromparkinsonsdisease
AT alexandergluch queenslandparkinsonsprojectanoverviewof20yearsofmortalityfromparkinsonsdisease
AT peterasilburn queenslandparkinsonsprojectanoverviewof20yearsofmortalityfromparkinsonsdisease
AT georgedmellick queenslandparkinsonsprojectanoverviewof20yearsofmortalityfromparkinsonsdisease
_version_ 1724321929158983680